Prognostic significance of body mass index before treatment for head and neck cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|10|1518-1523

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.10, 2015-10, pp. : 1518-1523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ifosfamide in the Treatment of Head and Neck Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

By  

Oncology, Vol. 83, Iss. 2, 2012-07 ,pp. : 108-116

Karger

Access to resources Recommend Favorite

Quantifying fibrosis in head and neck cancer treatment: An overview

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1225-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Treatment Options in Head and Neck Cancer

By  

Oncology Research and Treatment, Vol. 40, Iss. 6, 2017-05 ,pp. : 342-346

Karger

Access to resources Recommend Favorite

Prognostic role of neutrophil‐to‐lymphocyte ratio in head and neck cancer: A meta‐analysis

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 647-655

John Wiley & Sons Inc

Access to resources Recommend Favorite